MedTrace Logo

CIRSE Emprint Microwave Ablation Registry

NCT03775980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-05-13

No results posted yet for this study

Summary

Observation of the clinical use of the Emprint Microwave Ablation System for the ablation of Liver Metastases of Colorectal Adenocarcinoma.

Conditions

  • Colorectal Neoplasms Malignant
  • Neoplasm Metastasis

Interventions

DEVICE

Emprint Microwave Ablation System

Microwave Ablation of colorectal liver metastases

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Cardiovascular and Interventional Radiological Society of Europe

    lead OTHER

Principal Investigators

  • Phillippe L. Pereira, PhD · Radiology, Minimally Invasive Therapies and Nuclear Medicine at SLK Clinics Heilbronn GmbH, Germany

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-04
Primary Completion
2023-01-03
Completion
2026-01-31

Countries

  • Croatia
  • Denmark
  • France
  • Germany
  • Greece
  • Italy
  • Lithuania
  • Netherlands
  • North Macedonia
  • Norway
  • Portugal
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03775980 on ClinicalTrials.gov